The "largest genetic
association study of blood pressure traits" to date has studied over 1
million people and found 535 new genetic loci linked with the condition. This
finding may help predict the risk of high blood pressure and identify better
treatments.
DNA plays a much larger role in the
development of high blood pressure than previously believed.
The American Heart Association (AHA)
suggest that more than 100 million people in the United States now have high blood pressure.
That number equates to almost half
of all adults who reside in the country.
Worldwide, the condition is the
leading cause of cardiovascular death.
In the U.S., the number of deaths
resulting from high blood pressure increased by 38 percent in 2005–2015. High
blood pressure can cause many serious conditions, such as heart attack, stroke, heart failure,
kidney failure, and the loss of vision, among several others.
Risk factors for high blood pressure are also numerous
and can be divided into modifiable and non-modifiable ones.
A lack of physical activity,
smoking, an unhealthful diet, excessive alcohol intake, stress, and being
overweight are some factors that heighten risk but that can be changed or
modified.
However, race, sex, genes, and age
can also influence risk, and such factors cannot be changed. That being said,
just being aware of them can help a person make lifestyle changes that could
offset the risk.
New research delves deeper into the
genetic risk factors. A team led by scientists at Queen Mary University of
London and Imperial College London — both in the United Kingdom — reviewed the
genetic data of over 1 million people and found more than 500 new genetic
regions that could be responsible for high blood pressure.
Researcher Prof. Mark Caulfield,
from Queen Mary University of London, is a co-corresponding author of the
paper. The team's findings have recently been published in
the journal Nature Genetics.
Uncovering
535 new genetic locations
Prof. Caulfield and his colleagues
analyzed genetic and blood pressure data
from the UK Biobank database and the International Consortium of Blood Pressure
Genome Wide Association Studies.
In total, they studied the DNA of
over 1 million European participants and cross-referenced it with data on their
systolic, diastolic, and pulse blood pressure.
Overall, the researchers identified
535 new genetic loci associated with high blood pressure. This accounts for
almost a third (27 percent) of "the estimated heritability for blood
pressure," explain the study authors.
More specifically, the study
revealed that people who were in the highest genetic risk group had a blood
pressure that was 13 millimeters of mercury higher, on average, than those in
the lowest genetic risk group.
Also, people in this group were 3.34
times more likely to develop hypertension and 1.52
times more likely to have more serious cardiovascular problems.
Finally, the study points to some
potential new drug targets and ways in which existing drugs could serve to
treat hypertension.
Because one of the newly discovered
genetic locations, for instance, is targeted by a drug for type 2 diabetes, the drug could be used to
treat patients with hypertension who did not respond to other treatments.
'Preventing
thousands of heart attacks'
Prof. Caulfield comments on the
significance of the new findings, saying, "This is the most major advance
in blood pressure genetics to date."
"We now know that there are
over 1,000 genetic signals which influence our blood pressure," he adds.
This provides us with many new insights into how our bodies regulate blood
pressure and has revealed several new opportunities for future drug
development.
"With this information, we
could calculate a person's genetic risk score for high blood pressure in later
life," Prof. Caulfield says. "Taking a precision medicine approach,
doctors could target early lifestyle interventions to those with a high genetic
risk, such as losing weight, reducing alcohol consumption, and increasing
exercise."
Co-lead
researcher Prof. Paul Elliott, at Imperial College London, echoes the same
sentiments, claiming, "Identifying these kinds of genetic signals will
increasingly help us to split patients into groups based on their risk of
disease."
"By identifying those patients
who have the greatest underlying risk, we may be able to help them to change
lifestyle factors which make them more likely to develop disease, as well as
enabling doctors to provide them with targeted treatments earlier, reducing the
burden of disease on the health service, and increasing people's quality of
life."
Prof. Jeremy Pearson — an associate
medical director at the British Heart Foundation, a nonprofit organization that
co-funded the research — also chimes in.
According to him, "Knowing
which genes cause high blood pressure may help us to spot the people who are at
risk, before the damage is done.
"Those at risk can be treated —
either with medication or lifestyle changes — potentially preventing thousands
of heart attacks and strokes every year."
No comments:
Post a Comment